BioLine RX Ltd Capital Reinvestment Ratio

Latest as of December 2023: 0.00x

BioLine RX Ltd capital reinvestment ratio. BioLine RX Ltd (BLRX) has a Capital Reinvestment Ratio of 0.00x as of December 2023, meaning it reinvests 0% of its operating cash flow (ILA4.99 Million) in capital expenditures (ILA18.00K). Check BioLine RX Ltd (BLRX) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

0.00x

Capex / Operating Cash Flow

Operating Cash Flow

ILA4.99 Million

ILA

Capital Expenditures

ILA18.00K

ILA

Data as of

Dec 2023

Most recent filing

Capital Reinvestment Ratio of BioLine RX Ltd (2010–2010)

Capital reinvestment ratio of BioLine RX Ltd from 2010 to 2010. This chart tracks BioLine RX Ltd's Capital Reinvestment Ratio across 1 annual periods. Also explore BioLine RX Ltd equity growth rate to track the company's year-over-year net asset growth rate.

BioLine RX Ltd Capital Reinvestment Ratio by Year (2010–2010)

BioLine RX Ltd capital reinvestment ratio by year from 2010 to 2010. For the full cash flow conversion analysis, see BLRX operating cash flow.

Year	Reinvestment Ratio	Operating CF (ILA)	Capital Expenditures	YoY Change
2010	0.06x	ILA11.46 Million	ILA660.94K	—

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow